Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a new version release with likely improvements or bug fixes.
    Difference
    0.3%
    Check dated 2024-06-13T21:45:44.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:37:03.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 02 29 to 05 23, indicating a recent update in the information related to Medical and healthcare publications and documentation.
    Difference
    0.7%
    Check dated 2024-05-24T03:54:18.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of relevant medical and healthcare-related publications or documentation. This change may reflect new information or additional studies being included in the database.
    Difference
    0.3%
    Check dated 2024-05-22T21:32:46.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:52:10.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.